A combination of iontophoresis and the chelating agent 1, 10 phenanthroline act synergistically as penetration enhancers

AAPS pharmSci

Volumn 2, Issue 4, 2000, Pages 19-

  Brand, Rhonda M ^a   Hannah, Tracy L ^b   Hamel, Frederick G ^b,c  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b Section of Diabetes   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 1,10-PHENANTHROLINE; 1,7 PHENANTHROLINE; 1,7-PHENANTHROLINE; ALANINE; BISPEROXO(1,10 PHENANTHROLINE)OXOVANADATE(1 ); BISPEROXO(1,10-PHENANTHROLINE)OXOVANADATE(1-); CHELATING AGENT; EDETIC ACID; LEUCINE; ORGANOMETALLIC COMPOUND; PHENANTHROLINE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; HUMAN; IONTOPHORESIS; METABOLISM; MOUSE; MOUSE STRAIN; PERMEABILITY; SKIN ABSORPTION;

ALANINE; ANIMAL; CHELATING AGENTS; COMPARATIVE STUDY; EDETIC ACID; HUMAN; IONTOPHORESIS; LEUCINE; MICE; MICE, INBRED HRS; ORGANOMETALLIC COMPOUNDS; PERMEABILITY; PHENANTHROLINES; SKIN ABSORPTION; SUPPORT, NON-U.S. GOV'T;

EID: 18044402481     PISSN: None     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/ps020435     Document Type: Article

References (15)

1. 1. AP Bevan JW Burgess JF Yale 1995 in vivo insulin mimetic effects of pV compounds role for tissue targeting Am J Physiol 268 E60 66 1:CAS:528:DyaK2MXktFWqs7s%3D 7840184 Bevan AP, Burgess JW, Yale JF et al in vivo insulin mimetic effects of pV compounds role for tissue targeting Am J Physiol. 1995;268:E60–66.
2. 2. BI Posner R Faure JW Burgess 1994 Peroxovanadium compounds, a new class of potent phosphotyrosine phosphatase inhibitors which are unsulin mimetics J Biol Chem 296 4596 4604 Posner BI, Faure R, Burgess JW, et al. Peroxovanadium compounds, a new class of potent phosphotyrosine phosphatase inhibitors which are unsulin mimetics. J Biol Chem. 1994;296:4596–4604.
3. 3. RM Brand FG Hamel 1999 Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats Int J Pharm 183 117 123 1:CAS:528:DyaK1MXjsFKlsbo%3D 10361162 10.1016/S0378-5173(99)00071-X Brand RM, Hamel FG. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats. Int J Pharm. 1999;183:117–123.
4. 4. RM Brand G Duensing FG Hamel 1997 Iontophoretic delivery of an insulin-mimetic peroxovanadium compound Int J Pharm 146 115 122 1:CAS:528:DyaK2sXhtlyrt7w%3D 10.1016/S0378-5173(96)04781-3 Brand RM, Duensing G, Hamel FG. Iontophoretic delivery of an insulin-mimetic peroxovanadium compound. Int J Pharm. 1997;146:115–122.
5. 5. PW Ledger 1992 Skin biological issues in electrically enhanced transdermal delivery Adv Drug Del Rev 9 289 307 1:CAS:528:DyaK38XltFyhtLg%3D 10.1016/0169-409X(92)90027-N Ledger PW. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Del Rev. 1992;9:289–307.
6. 6. A Kim PG Green G Rao RH Guy 1993 Convective solvent flow across the skin during iontophoresis Pharm Res 10 1315 1320 1:CAS:528:DyaK3sXmtleqsLY%3D 8234169 10.1023/A:1018969713547 Kim A, Green PG, Rao G, Guy RH. Convective solvent flow across the skin during iontophoresis. Pharm Res. 1993;10:1315–1320.
7. 7. JB Phipps JR Gyory 1992 Transdermal ion migration Adv Drug Del Rev 9 137 176 1:CAS:528:DyaK38XltFyhtL8%3D 10.1016/0169-409X(92)90022-I Phipps JB, Gyory JR. Transdermal ion migration. Adv Drug Del Rev. 1992;9:137–176.
8. 8. P Singh HI Maibach 1996 Ionrophoresis: an alternative to the use of carriers in cutaneous drug delivery Adv Drug Del Rev 18 379 394 1:CAS:528:DyaK28XhtlWhsL4%3D 10.1016/0169-409X(95)00082-I Singh P, Maibach HI. Ionrophoresis: an alternative to the use of carriers in cutaneous drug delivery. Adv Drug Del Rev. 1996;18:379–394.
9. 9. MB Delgado-Charro RH Guy 1995 Intophoretic delivery of nafarelin across the skin Int JPharma 117 165 172 1:CAS:528:DyaK2MXktlCjtbg%3D 10.1016/0378-5173(94)00323-W Delgado-Charro MB, Guy RH. Intophoretic delivery of nafarelin across the skin. Int JPharma. 1995;117:165–172.
10. 10. P Knoblauch F Moll 1993 In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis J Control Release 26 203 212 1:CAS:528:DyaK3sXmslymt70%3D 10.1016/0168-3659(93)90187-A Knoblauch P, Moll F. In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis. J Control Release. 1993;26:203–212.
11. 11. M Nakakura M Terajima Y Kato E Hayakawa K Ito T Kuroda 1995 Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally J Drug Target 2 487 492 1:CAS:528:DyaK2MXjvVCnsbY%3D 7773610 10.3109/10611869509015918 Nakakura M, Terajima M, Kato Y, Hayakawa E, Ito K, Kuroda T. Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally. J Drug Target 1995;2:487–492.
12. 12. MR Prausnitz 1996 The effects of electric current applied to skin: a review for transdermal drug delivery Adv Drug Del Rev 18 395 425 1:CAS:528:DyaK28XhtlWhsL8%3D 10.1016/0169-409X(95)00081-H Prausnitz MR. The effects of electric current applied to skin: a review for transdermal drug delivery. Adv Drug Del Rev. 1996;18:395–425.
13. 13. J Hirvonen F Hueber RH Guy 1995 Current profile regulates iontophoretic delivery of amino acids across the skin J Control Release 37 239 249 1:CAS:528:DyaK2MXhtVSgt7vJ 10.1016/0168-3659(95)00081-X Hirvonen J, Hueber F, Guy RH. Current profile regulates iontophoretic delivery of amino acids across the skin. J Control Release 1995;37:239–249.
14. 14. NG Turner YN Kalia RH Guy 1997 The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis Pharm Res 14 1252 1257 1:CAS:528:DyaK2sXmsFehu7s%3D 9327457 10.1023/A:1012175428181 Turner NG, Kalia YN, Guy RH. The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis. Pharm Res. 1997;14:1252–1257.
15. 15. CH Chiang CH Shao JL Chen 1998 Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide Drug Dev. Indus. Pharm 24 431 438 1:CAS:528:DyaK1cXjt1ertbw%3D 10.3109/03639049809085640 Chiang CH, Shao CH, Chen JL. Effects of pH, electric current, and enzyme inhibitors on iontophoresis of delta sleep-inducing peptide. Drug Dev. Indus. Pharm. 1998;24:431–438.